0 Комментарии
0 Поделились
360 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Reels
-
Статьи пользователей
-
Маркет
-
Offers
-
Jobs
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Cat Eye Syndrome Industry: Rare Disease Research, Clinical developments & Future OutlookAccording to the latest report published by Data Bridge Market Research, the Cat Eye Syndrome Market CAGR Value The global cat eye syndrome market size was valued at USD 2.59 billion in 2024 and is expected to reach USD 3.18 billion by 2032, at a 2.60% during the forecast period The Cat Eye Syndrome Market document has wide-ranging and comprehensive market...0 Комментарии 0 Поделились 14 Просмотры 0 предпросмотр
-
Chenodeoxycholic Acid Market – Bile Acid Therapeutics Gaining Ground in Rare Disease TreatmentMarket Overview The chenodeoxycholic acid market is gaining momentum as clinicians increasingly rely on this naturally occurring bile acid to manage cholesterol gallstones and rare metabolic disorders such as cerebrotendinous xanthomatosis. Chenodeoxycholic acid works by reducing hepatic cholesterol synthesis and dissolving cholesterol-based stones, making it a valuable non-surgical option for...0 Комментарии 0 Поделились 477 Просмотры 0 предпросмотр
-
Could Advancements in Rare Disease Care Strengthen the Systemic Light Chain (AL) Amyloidosis Market?According to the latest report published by Data Bridge Market Research, the Systemic Light Chain (AL) Amyloidosis Market CAGR Value The idea of this Systemic Light Chain (AL) Amyloidosis Market research document is high level analysis of major market segments and recognition of opportunities in Systemic Light Chain (AL) Amyloidosis Market industry. Experienced and...0 Комментарии 0 Поделились 579 Просмотры 0 предпросмотр
-
Emerging Opportunities in the Rare Disease Diagnostics MarketPolaris Market Research presents its latest market research report, titled Rare Disease Diagnostics Market Size, Share, Trends & Forecast, 2026–2034. It is a comprehensive market research report analyzing the fast-evolving rare disease diagnostics market. The report offers insight into the current market landscape, drivers for growth, emerging trends, competitive dynamics,...0 Комментарии 0 Поделились 347 Просмотры 0 предпросмотр
-
Expanding Access to Rare Disease Care Supporting Market GrowthAccording to a new report by Polaris Market Research, the MENA Gaucher Disease Treatment market was valued at USD 136.66 million in 2024 and is projected to reach USD 178.35 million by 2034, expanding at a CAGR of 2.8% over the forecast period. Growth is underpinned by the expansion of centralized healthcare systems, growing public-private partnerships, and rising investment in rare...0 Комментарии 0 Поделились 483 Просмотры 0 предпросмотр
-
Expanding Horizons in the Rare Neurodegenerative Disease Treatment MarketThe Rare Neurodegenerative Disease Treatment Market is witnessing an unprecedented rise in treatment volumes, marking a significant shift in the healthcare landscape. With the market size expected to escalate to $0.377 billion by 2035, the increasing demand is fueled by a growing understanding of rare neurodegenerative diseases and the need for effective therapies. The projected CAGR of 5.93%...0 Комментарии 0 Поделились 540 Просмотры 0 предпросмотр
-
From Diagnosis to Lifelong Care: The Expanding Role of Rare Disease Therapeutics and Genetic Disorder TreatmentThe journey from diagnosis to lifelong care for individuals with Fragile X Syndrome has been transformed by advances in therapeutic approaches that address the diverse needs of patients across the lifespan. Rare disease therapeutics have emerged as essential tools in this journey, providing targeted interventions that address the underlying neurobiological mechanisms of the condition....0 Комментарии 0 Поделились 428 Просмотры 0 предпросмотр
-
From Pediatric to Adult Care: The Expanding Role of Rare Neurological Disorders and Metabolic Disease TreatmentThe management of GABA transaminase deficiency encompasses a broad spectrum of patients, from pediatric cases diagnosed in infancy to adults with previously unrecognized or milder forms of the condition. Rare neurological disorders have evolved to meet the diverse needs of these populations, with metabolic disease treatment offering interventions across the lifespan. The Gamma-Aminobutyric...0 Комментарии 0 Поделились 441 Просмотры 0 предпросмотр
-
From Rare Disease to Drug Discovery: Clinical Applications Driving the Whole Exome Sequencing MarketThe clinical applications of whole exome sequencing span diverse healthcare settings, from rare disease diagnosis and oncology to pharmacogenomics and reproductive health. The Whole Exome Sequencing Market is benefiting from this diverse demand, valued at USD 2.52 billion in 2025 and projected to reach USD 11.50 billion by 2035 at a CAGR of 16.4%. This article explores the clinical...0 Комментарии 0 Поделились 431 Просмотры 0 предпросмотр
-
How Rare Disease Research Is Driving the Rathke's Cleft Cyst MarketRathke’s Cleft Cyst Market According to the latest report published by Data Bridge Market Research, the Rathke’s Cleft Cyst Market Rathke’s cleft cyst market size was valued at USD 400.50 million in 2024 and is expected to reach USD 556.60 million by 2032, at a CAGR of 4.20% during the forecast period The market growth is primarily...0 Комментарии 0 Поделились 392 Просмотры 0 предпросмотр
-
Is Your Pharma Business Ready to Capture Asia-Pacific's Next Rare Disease Opportunity?Asia-Pacific Lymphangioleiomyomatosis (LAM) Market According to the latest report published by Data Bridge Market Research, the Asia-Pacific Lymphangioleiomyomatosis (LAM) Market The Asia-Pacific Lymphangioleiomyomatosis (LAM) market size was valued at USD 16.14 million in 2024 and is expected to reach USD 22.78 million by 2032, at a CAGR of 4.40% during...0 Комментарии 0 Поделились 579 Просмотры 0 предпросмотр
-
Aromatase Deficiency Market: Global Pharmaceutical Companies, Hormone Therapies and Industry Growth Outlook"According to the latest report published by Data Bridge Market Research, the Aromatase Deficiency Market CAGR Value Data Bridge Market Research analyses that the aromatase deficiency market was valued at USD 90.45 million in 2021 and is expected to reach USD 109.35 million by 2029, registering a CAGR of 2.40% during the forecast period of 2022 to 2029 The reliable Aromatase...0 Комментарии 0 Поделились 517 Просмотры 0 предпросмотр
-
Autoimmune Polyglandular Syndrome Type 1 Market InsightsAutoimmune Polyglandular Syndrome Type 1 (APS-1) is a rare inherited autoimmune disorder characterized by the dysfunction of multiple endocrine glands, resulting in chronic health complications that require lifelong medical management. Growing awareness of rare autoimmune diseases, advancements in diagnostic technologies, and increasing investments in targeted therapies are contributing...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Connective Tissue Disease Market Forecast: Emerging Therapies and Growth OpportunitiesConnective tissue diseases (CTDs) represent a group of autoimmune and inflammatory disorders that affect the body's connective tissues, including joints, skin, blood vessels, muscles, and internal organs. Rising awareness of autoimmune disorders, advancements in diagnostic technologies, increasing healthcare spending, and the introduction of innovative biologic therapies are contributing...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Fabry Disease Treatment Market to Reach USD 3.67 Billion by 2033, Growing at 6.9% CAGRThe global Fabry disease treatment market size was valued at USD 2.01 billion in 2024 and is expected to grow from USD 2.15 billion in 2025 to USD 3.67 billion by 2033, growing at a CAGR of 6.9% during the forecast period (2025-2033). According to Straits Research, this report provides a clear understanding of the Fabry Disease Treatment Market by analyzing its overall structure, key...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Gitelman Syndrome Treatment Market: Drug Providers, Treatments and Industry Outlook"According to the latest report published by Data Bridge Market Research, the Gitelman Syndrome (GS) Treatment Market CAGR ValueData Bridge Market Research analyses that the global gitelman syndrome (GS) treatment market which was USD 184.12 million in 2022, is expected to reach USD 315.12 million by 2030, and is expected to undergo a CAGR of 5.5% during the forecast period of 2023...0 Комментарии 0 Поделились 164 Просмотры 0 предпросмотр
-
Global Fragile X Syndrome (FXS) Treatment Market: Therapeutic Trends, Drug Innovation, Demand, and OutlookAccording to the latest report published by Data Bridge Market Research, the Fragile X Syndrome (FXS) Treatment Market CAGR Value The global fragile X syndrome (FXS) treatment market size was valued at USD 2.64 billion in 2024 and is expected to reach USD 3.99 billion by 2032, at a CAGR of 5.30% during the forecast period Winning Fragile X...0 Комментарии 0 Поделились 499 Просмотры 0 предпросмотр
-
Global Poland Syndrome Market Size, Share, Trends and Growth OpportunitiesAccording to the latest report published by Data Bridge Market Research, the Poland Syndrome Market CAGR Value The Poland Syndrome Market was valued at USD 72.20 million in 2025 and is projected to reach USD 100.11 million by 2033, growing at a CAGR of 4.17% from 2026 to 2033. Poland Syndrome Market survey report is intended to help the readers...0 Комментарии 0 Поделились 365 Просмотры 0 предпросмотр
-
Netherton Syndrome Market Competitive Landscape and Key PlayersThe global Netherton syndrome market is witnessing remarkable growth due to increasing awareness regarding rare genetic skin disorders, rising investments in orphan drug development, and expanding research activities focused on innovative dermatological therapies. Netherton syndrome is a rare autosomal recessive genetic disorder characterized by chronic skin inflammation, hair shaft...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Periodic Paralysis Treatment Market Growth Drivers and Investment OpportunitiesPeriodic paralysis is a rare neuromuscular disorder characterized by episodes of muscle weakness or paralysis caused by abnormalities in ion channels. The increasing prevalence of rare neuromuscular disorders, growing awareness regarding genetic diseases, and rising demand for advanced treatment solutions are significantly contributing to industry expansion. Pharmaceutical companies and...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Plasma Fractionation Market: Advanced Fractionation Technologies & Industry TrendsPlasma Fractionation Market: Growth, Trends, Demand & Forecast to 2033 Plasma Fractionation Market Overview The global Plasma Fractionation Market is witnessing steady expansion as demand for plasma-derived therapies continues to increase across healthcare systems. The market was valued at approximately USD 34.4 billion in 2025 and is projected to reach USD...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Rare Disease Genetic Testing Market Growth, Analysis, Trends, Recent Developments and Forecast Analysis By Fact.MRRockville, Maryland – October 15, 2026 — The global rare disease research genomics services market is projected to grow from USD 587.7 million in 2026 to USD 1,222.6 million by 2036, according to the latest market report published by Fact.MR. The industry is anticipated to expand at a compound annual growth rate (CAGR) of 7.6% over the forecast period, reflecting rising demand for...0 Комментарии 0 Поделились 60 Просмотры 0 предпросмотр
Расширенные страницы
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek